Cancer Therapy News and Research

RSS

Novel genetic discovery identifies new avenues for prostate cancer treatment

A genetic discovery out of the University of Pittsburgh School of Medicine is leading to a highly accurate test for aggressive prostate cancer and identifies new avenues for treatment.

17 Sep 2014

Breast cancer screening in older women leads to overdiagnosis, say researchers

Instead, it may just lead to overdiagnosis and overtreatment, suggest the researchers, led by a team based at Leiden University Medical Centre in the Netherlands.

17 Sep 2014

Cochrane Review rejects safety concerns regarding cheap alternative drug for treating eye disease

Health policies which favour using ranibizumab for treating eye disease in older people over safety concerns for a cheaper alternative should take account of a new Cochrane Review published today.

16 Sep 2014

Ramucirumab Phase III study meets primary endpoint in patients with metastatic colorectal cancer

Eli Lilly and Company today announced that the RAISE trial, a Phase III study of ramucirumab (CYRAMZA) in combination with chemotherapy in patients with metastatic colorectal cancer (mCRC), met its primary endpoint of overall survival.

15 Sep 2014

Research roundup: Prevention services for seniors; drug shortages

This policy brief reports the findings of a systematic review conducted by the Community Health Innovations in Prevention for Seniors (CHIPS) project. ... Clinical preventive services such as colorectal cancer screening and pneumococcal immunization can help reduce rates of premature death and disability. Yet, many older adults are not receiving the full set of clinical preventive services that have been proven effective and are considered "high value" in terms of their costs per life saved. Rates are particularly low among racial and ethnic minority older adults compared to national goals.

15 Sep 2014

MRI and PET techniques can help monitor response of bone metastases to treatment

Imaging technologies are very useful in evaluating a patient's response to cancer treatment, and this can be done quite effectively for most tumors using RECIST, Response Evaluation Criteria in Solid Tumors.

11 Sep 2014

Researchers pave way for development of new generation of chemotherapy drugs

A new mechanism to inhibit proteasomes, protein complexes that are a target for cancer therapy, is the topic of an article published in the journal Chemistry & Biology.

10 Sep 2014

Experts share tips on prevention of prostate cancer

Prostate cancer is the second leading cause of cancer death in American men. One in seven men will be diagnosed with prostate cancer and 233,000 new cases are diagnosed annually.

9 Sep 2014

UT Southwestern Medical Center's multi-disciplinary wound care efforts

UT Southwestern Medical Center's multi-disciplinary wound care efforts have converged in a new, state-of-the-art clinic.

9 Sep 2014

New breast cancer vaccine provides evidence of immunotherapy in preventing disease recurrence

A new breast cancer vaccine candidate, (GP2), provides further evidence of the potential of immunotherapy in preventing disease recurrence. This is especially the case for high-risk patients when it is combined with a powerful immunotherapy drug.

8 Sep 2014

Researchers to study effectiveness of atorvastatin in preventing heart problems in breast cancer patients

Wake Forest Baptist Medical Center has been awarded $4.4 million to conduct a multiple-site clinical trial testing the effectiveness of a statin drug in preventing cardiovascular events in women treated for breast cancer.

5 Sep 2014

Keytruda drug gets FDA approval for treatment of advanced melanoma

The U.S. Food and Drug Administration today approved a new immunotherapy drug to treat advanced melanoma, signaling a paradigm shift in the way the deadly skin cancer is treated.

5 Sep 2014

Oncolytics Biotech completes randomized Phase 2 study of ovarian, fallopian tube cancer

Oncolytics Biotech Inc. today announced that patient enrollment has been completed in a randomized Phase 2 study of paclitaxel plus REOLYSIN® versus paclitaxel alone in patients with persistent or recurrent ovarian, fallopian tube or primary peritoneal cancer (GOG186H).

4 Sep 2014

Nature of chemicals released into water became problem with air quality

Andrea Dietrich and Amanda Sain of Virginia Tech's Via Department of Civil and Environmental Engineering estimated that 50 percent of the population taste threshold for manganese II in water, the simplest ionic manganese oxide, to be more than 1000 times the current EPA allowable level.

4 Sep 2014

Research to identify cancer-busting 'genetic partners' can personalize cancer treatment

Despite the revolutionary biotechnological advancements of the last few decades, an ideal anti-cancer treatment - one that's immediately lethal to cancer cells, harmless to healthy cells, and resistant to cancer's relapse - is still a dream.

4 Sep 2014

Clinical trial to assess safety and efficacy of novel monoclonal antibody for CLL patients

Researchers at the University of California, San Diego School of Medicine, in partnership with the California Institute for Regenerative Medicine (CIRM) and Celgene Corporation, a New Jersey-based biopharmaceutical company, have launched a phase 1 human clinical trial to assess the safety and efficacy of a novel monoclonal antibody for patients with chronic lymphocytic leukemia (CLL).

4 Sep 2014

Clinical studies to treat unmet medical need post-transplantation

A class of biotechnology drugs called monoclonal antibodies is now being tested in clinical studies to treat an unmet medical need post-transplantation, called delayed graft function

3 Sep 2014

Travel time to breast imaging services in United States varies dramatically by modality

Mammography, ultrasound, and MRI - or a combination of these examinations - are critical in detecting, diagnosing, and characterizing the extent of breast cancer.

2 Sep 2014

VentiRx's motolimod receives FDA Fast Track designation for ovarian cancer treatment

VentiRx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company committed to the development and commercialization of novel Toll-like receptor 8 (TLR8) immunotherapies, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to the investigation of motolimod (VTX-2337) when administered in combination with pegylated liposomal doxorubicin (PLD) for the treatment of women with ovarian cancer whose disease has progressed on or recurred after platinum-based chemotherapy.

2 Sep 2014

UT Southwestern faculty awarded CPRIT grants to combat cancer

UT Southwestern Medical Center faculty have received 19 grants totaling more than $26 million from the Cancer Prevention and Research Institute of Texas to expand cancer screenings, investigate the effectiveness and viability for cancer therapies and radiation treatments, conduct research into cancer biology, and recruitment.

29 Aug 2014

Cancer Therapy News and Research

Novel genetic discovery identifies new avenues for prostate cancer treatment

Breast cancer screening in older women leads to overdiagnosis, say researchers

Cochrane Review rejects safety concerns regarding cheap alternative drug for treating eye disease

Ramucirumab Phase III study meets primary endpoint in patients with metastatic colorectal cancer

Research roundup: Prevention services for seniors; drug shortages

MRI and PET techniques can help monitor response of bone metastases to treatment

Researchers pave way for development of new generation of chemotherapy drugs

Experts share tips on prevention of prostate cancer

UT Southwestern Medical Center's multi-disciplinary wound care efforts

New breast cancer vaccine provides evidence of immunotherapy in preventing disease recurrence

Researchers to study effectiveness of atorvastatin in preventing heart problems in breast cancer patients

Keytruda drug gets FDA approval for treatment of advanced melanoma

Oncolytics Biotech completes randomized Phase 2 study of ovarian, fallopian tube cancer

Nature of chemicals released into water became problem with air quality

Research to identify cancer-busting 'genetic partners' can personalize cancer treatment

Clinical trial to assess safety and efficacy of novel monoclonal antibody for CLL patients

Clinical studies to treat unmet medical need post-transplantation

Travel time to breast imaging services in United States varies dramatically by modality

VentiRx's motolimod receives FDA Fast Track designation for ovarian cancer treatment

UT Southwestern faculty awarded CPRIT grants to combat cancer

Event guide: 7th Allogeneic Cell Therapies Summit eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News